Dr. Sherry Levinson
speaker
24 appearances
1 recordings
1 series
first heard Aug 2026
last heard 7 Aug
Dr. Sherry Levinson’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Aug 2026 with 1.
Appearances
We know that across all eating disorders, regardless of diagnosis, anorexia nervosa, bulimia nervosa, binge eating disorder, atypical anorexia nervosa.
We know that restriction is one of the primary reasons that people continue to develop and continue on with their eating disorder.
So restriction is actually one of the really core behaviors of all eating disorders, and it also can cause people to develop.
It can cause people to relapse from eating disorders.
And so any sort of medication that is enhancing restrictive behaviors is really, really risky for a population whose primary problematic behavior is restriction.
Because essentially what these drugs are doing is mimicking appetite suppressant restriction.
It's helping people be able to eat less.
And when you have folks who are very vulnerable, so people with eating disorders, this can just be really, really risky and maintain their eating disorder and make people sicker and cause lots of impairment and medical complications.
Yeah, so we know that eating disorders are genetically based illnesses.
So we know that certain people have genetic tendencies to develop eating disorders.
And then when you add on restriction or rapid weight loss that comes from restriction, that's really what pulls the trigger and makes someone develop an eating disorder.
What that means is that we are starting to hear about lots of folks across the country who did not have eating disorders but went on a GLP-1 and now they have developed an eating disorder because of the restriction that was started by being on the GLP-1.
And I was just also going to add that in general, I think that if people are going to a doctor, it's very rare that the doctors are screening for peptides.
eating disorders.
I think the statistic for that is that within medical school, there's something like 45 minutes to an hour worth of training in eating disorders.
And so when you talk to physicians, most are not screening for eating disorders or don't know how to screen for eating disorders.
And that is something I think that we can do a better job of making sure that prescribers know exactly
Number one, assess for eating disorders.
And number two, how to assess for eating disorders, especially when prescribing GLP-1s.
There may need to be some sort of warning that medications are not researched enough for use for eating disorders and have potential to cause harm in eating disorders.
Showing 1–20 of 24 · page 1 of 2
Next →